Cargando…
Steroid in the Treatment of Outpatient COVID-19: A Multicenter Randomized Controlled Trial
BACKGROUND: Early treatment of COVID-19 patients could reduce hospitalization and death. The effect of corticosteroids in the outpatient setting is still unknown. This study aimed to determine the effect of corticosteroids in the prevention of hospitalization of nonsevere cases. MATERIALS AND METHOD...
Autores principales: | Amra, Babak, Vaezi, Atefeh, Soltaninejad, Forogh, Salahi, Mehrdad, Salmasi, Mehrzad, Haghjooy Javanmard, Shaghayegh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331530/ https://www.ncbi.nlm.nih.gov/pubmed/37434926 http://dx.doi.org/10.4103/abr.abr_72_22 |
Ejemplares similares
-
Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
por: Vaezi, Atefeh, et al.
Publicado: (2023) -
Cardiac involvement according to echocardiographic findings in severe coronavirus disease 2019
por: Tajmirriahi, Marzieh, et al.
Publicado: (2021) -
Non Invasive Ventilation's Effectiveness (NIV) in Patients with Interstitial Lung Disease and Hypercapnic Respiratory Failure
por: Soltaninejad, Forogh, et al.
Publicado: (2022) -
Thalidomide for the Treatment of COVID-19 Pneumonia: A Randomized Controlled Clinical Trial
por: Amra, Babak, et al.
Publicado: (2023) -
Metabolic syndrome in migraine headache: A case-control study
por: Salmasi, Mehrzad, et al.
Publicado: (2014)